ArticleInternational journal of chronic obstructive pulmonary disease

Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results.

Martine Hoogendoorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.